StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)

Close on Nov 18, 2026Market cap $56.14MP/E –Yield –

Oncolytics Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oncolytics Biotech's price to sales ratio was 79.2× on Feb 28, 2020, against 6.0× a year earlier. Over the last 2 years it ranged from 5.6× to 180.4×, with a median of 22.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Feb 28, 202079.2×−101.2
2019Dec 31, 2019180.4×+174.9
2018Dec 31, 20185.6×–

More Oncolytics Biotech figures

See a number that looks wrong?